Name |
Alluzience 200 Speywood jedinica/ml otopina za injekciju |
Marketing Authorisation Number |
HR-H-907237616 |
Active Substance |
neurotoksin Clostridium Botulinum tip A - hemaglutininski kompleks |
Composition |
125 Speywood jedinica botulinskog toksina tipa A u 0,625 ml otopine u bočici |
Pharmaceutical Form |
otopina za injekciju |
Manufacturer |
Ipsen Manufacturing Ireland Ltd., Blanchardstown, Irska |
Marketing Authorisation Holder |
Ipsen Pharma, 65 Quai Georges Gorse, Boulogne-Billancourt, Francuska |
Marketing Authorisation Date |
18.09.2023 |
MA Period of Validity |
18.09.2028 |
Classification Number |
UP/I-530-09/23-01/194 |
Registration Number |
381-12-01/171-23-03 |
Prescription |
na recept |
Type of prescription |
ograničeni recept
|
Distribution |
u ljekarni |
Advertising to general public |
zabranjeno |
ATC Code |
M03AX01 |
Medicinal product marketed in the Croatia |
Da |
SmPC |
download |
PL |
download |
Public Assessment Report |
download
|
Summary of risk management plan |
download |